With the use of AR-negative PC-3 human prostate cancer–cell xenografts in the flank regions of mice, post-treatment with oral resveratrol (30 mg/kg/day) decreased the volume of tumors, with lowered tumor-cell proliferation and neovascularization, and induced apoptosis [214]. This evidence concerns the gene AR and prostate carcinoma.